MLKMFOTCPerfumes, Cosmetics & Other Toilet PreparationsAlso trades as MLKWF
Waldencast plc
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 13, 2026
$0.88−0.01 (-0.92%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q4 FY2025 Ended Dec 31, 2025 | Mar 13, 2026 | Before market open | $72.00M | – | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 18, 2025 | After market close | $72.10M | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 27, 2024 | After market close | $63.30M | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Jan 16, 2024 | Before market open | – | – | – |
Press releases
Announcements Waldencast filed with the SEC
Waldencast plc Announces First Half 2026 Financial Results
EX-99.1 to Form 6-K
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION
EX-99.1 to Form 6-K
Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint
EX-99.1 to Form 6-K
Waldencast Announces Sale of Obagi Medical to Bridgepoint
EX-99.1 to Form 6-K
Waldencast announces conclusion of SEC investigation
EX-99.1 to Form 6-K
Waldencast Reports Q4 2025 and FY 2025 Financial Results
EX-99.1 to Form 6-K
Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update
EX-99.1 to Form 6-K
WALDENCAST'S OPERATING AND FINANCIAL REVIEW AND PROSPECTS
EX-99.1 to Form 6-K
MILK MAKEUP LLC and OBAGI COSMECEUTICALS LLC,
EX-99.2 to Form 6-K
Q1 2025 Earnings Presentation 1
EX-99.1 to Form 6-K
Waldencast Reports Q1 2025 Financial Results
EX-99.1 to Form 6-K
FY 2024 Earnings Presentation 1
EX-99.1 to Form 6-K
Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results
EX-99.1 to Form 6-K
Q3 2024 Earnings Presentation 1
EX-99.1 to Form 6-K
Waldencast Reports Q3 2024 Financial Results
EX-99.1 to Form 6-K
Waldencast plc Announces Board Appointments and Annual General Meeting
EX-99.1 to Form 6-K
Q2 2024 Earnings Presentation 1
EX-99.1 to Form 6-K
Waldencast Reports Q2 2024 Financial Results
EX-99.1 to Form 6-K
WALDENCAST'S OPERATING AND FINANCIAL REVIEW AND PROSPECTS
EX-99.1 to Form 6-K
Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates
EX-99.1 to Form 6-K
Waldencast Reports Q1 2024 Financial Results
EX-99.1 to Form 6-K
Waldencast Reports Fiscal Year 2023 Financial Results
EX-99.1 to Form 6-K
Waldencast Regains Compliance with Nasdaq Filing Requirements
EX-99.1 to Form 6-K
Waldencast Reports First Half 2023 Results
EX-99.1 to Form 6-K
Waldencast Plc results for the first six months ended June 30, 2023
EX-99.2 to Form 6-K
Waldencast Receives Positive Nasdaq Listing Determination
EX-99.1 to Form 6-K